Navigation Links
Statin Side Effects Often Manageable: Study
Date:4/1/2013

By Amy Norton
HealthDay Reporter

MONDAY, April 1 (HealthDay News) -- Many people who quit taking their cholesterol-lowering statin drugs because of side effects can successfully try again, a new study suggests.

Researchers found that of more than 100,000 Boston-area adults who started a statin drug, 17 percent stopped taking it because of side effects -- most often, muscle aches. But within a year, more than half gave statins another chance, and most -- 90 percent -- were able to stick with it.

Experts said the findings, reported in the April 2 issue of the journal Annals of Internal Medicine, show that people need not abandon statins if a potential side effect crops up.

In some cases, the problem may not be caused by the drug at all, said senior researcher Dr. Alexander Turchin, of Brigham and Women's Hospital in Boston.

"Muscle pain can happen with statins," he said, "but it can also have many other causes."

In other cases, Turchin said, people are having a real side effect, but might do better with a lower dose or with a different statin.

"There are some people who simply cannot tolerate statins," Turchin said. "But in most cases, it's worth trying again."

A cardiologist not involved in the study agreed. "Just because you have a side effect doesn't mean you have to stop statins forever," said Dr. Tara Narula, associate director of the cardiac care unit at Lenox Hill Hospital in New York City.

If you think you're having a side effect, Narula said, you should talk to your doctor about it and not just stop the statin on your own. Your doctor will probably have you stop taking the drug for a couple weeks to see if the symptoms go away.

In the United States, about one-quarter of adults older than 45 are on statins, which include drugs such as simvastatin (Zocor), atorvastatin (Lipitor) and lovastatin (Mevacor). They are used to cut "bad" LDL cholesterol and help prevent heart disease, and run anywhere from around $10 to a few hundred dollars per month, depending on whether it's a generic or brand name.

The new findings are based on medical records for nearly 108,000 patients who started a statin between 2000 and 2008. When they stopped due to a side effect, the most common reason was muscle aches and pain, followed by other "musculoskeletal" problems such as joint pain or muscle spasms.

Doctors, as well as many patients, know that muscle pain is a potential statin side effect, so they may be quick to suspect the drug when aches arise, Narula noted.

"It's obviously important to listen to patients and take their complaints seriously," Narula said. But, she added, the problem comes when patients are taken off the statin and "the issue is never addressed again."

Besides muscle and joint problems, other statin side effects include nausea, diarrhea and constipation. More serious problems have been reported -- such as liver damage and a dangerous breakdown of the muscle called rhabdomyolysis -- but they are rare.

Statins have also been linked to an increased risk of type 2 diabetes, and to reports of memory problems in some users, according to the U.S. Food and Drug Administration. But it's not clear that the drugs are to blame.

Turchin said memory loss was reported for only 0.06 percent of patients in his study. "It was very uncommon in this group," he said.

Of all study patients who stopped their statin use due to side effects, nearly 60 percent tried again -- either the same statin or a different one. It's not clear why the other 40 percent did not.

"Maybe the patient didn't want to," Turchin said. "Or maybe the doctor didn't offer."

There are other ways to rein in high cholesterol. If LDL is moderately high, diet changes, exercise and shedding excess pounds may be enough. But for people who are at high risk of a heart attack -- because of past heart problems or conditions like diabetes -- doctors typically prescribe a statin right away.

It's estimated that about 5 percent to 10 percent of patients are truly "statin intolerant," said Dr. Scott Grundy, who wrote an editorial published with the study. If those patients are able to go back on a statin, it's often at a dose that doesn't cut LDL by much, said Grundy, of the University of Texas Southwestern Medical Center in Dallas.

But other types of cholesterol drugs might help, he added.

Drugs known as bile acid sequestrants and cholesterol absorption inhibitors can be used along with statins, according to the U.S National Heart, Lung, and Blood Institute.

For her part, Narula said, "Cardiovascular disease is the No. 1 killer in this country. Our ability to treat high cholesterol is one of the great tools we have against it."

The study was funded by government and private grants. Turchin has received research funds from Merck, which makes Zocor and Mevacor.

More information

Learn more about high cholesterol from the U.S. National Heart, Lung, and Blood Institute.

SOURCES: Alexander Turchin, M.D., researcher, endocrinology, Brigham and Women's Hospital, Boston; Tara Narula, M.D., associate director, cardiac care unit, Lenox Hill Hospital, New York City; April 2, 2013, Annals of Internal Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Benefits of Widespread Statin Use Outweigh Risks: Study
2. Statins prevent cancer in heart transplant recipients
3. Statins May Help Prevent Enlarged Prostate: Study
4. Pivotal role for proteins -- from helping turn carbs into energy to causing devastating disease
5. Are Statins Less Helpful for Women?
6. Turning off key piece of genetic coding eliminates toxic effect of statins, SLU research finds
7. Statins Heart Benefits Outweigh Diabetes Risk: Study
8. Statins Wont Hurt, Might Even Help, Your Pancreas: Study
9. Statin Use Tied to Possible Boost in Cataract Risk
10. New Drug May Help Those Who Cant Take Statins
11. Looking for the anti-Alzheimers molecule -- A new approach to treating a devastating disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statin Side Effects Often Manageable: Study
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: